Skip to main navigation Skip to search Skip to main content

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition

  • Barzin Y. Nabet
  • , Mohammad Shahrokh Esfahani
  • , Everett J. Moding
  • , Emily Hamilton
  • , Jacob J. Chabon
  • , Hira Rizvi
  • , Chloe B. Steen
  • , Aadel A. Chaudhuri
  • , Chih Long Liu
  • , Angela B. Hui
  • , Diego Almanza
  • , Henning Stehr
  • , Linda Gojenola
  • , Rene F. Bonilla
  • , Michael C. Jin
  • , Young Jun Jeon
  • , Diane Tseng
  • , Cailian Liu
  • , Taha Merghoub
  • , Joel W. Neal
    • Maximilian Diehn, Heather Wakelee, Sukhmani Kaur Padda, Kavitha Ramchandran, Millie Das, Andrew J. Plodkowski, Christopher H. Yoo, Emily L. Chen, Ryan B. Ko, Aaron M. Newman, Matthew D. Hellmann, Ash A. Alizadeh
  • Stanford University
  • Memorial Sloan-Kettering Cancer Center
  • Washington University St. Louis
  • Sungkyunkwan University
  • Cornell University
  • Parker Institute for Cancer Immunotherapy
  • Division of Oncology
  • U.S. Department of Veterans Affairs

Research output: Contribution to journal › Article › peer-review

297 Scopus citations

Fingerprint

Dive into the research topics of 'Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Medicine and Dentistry